Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation | Marea Therapeutics

Marea Therapeutics

About
Science
Pipeline
Careers
News

02/25/2022

Share

About
Careers
Home
News
Pipeline
Privacy Policy
Science
Terms and Conditions